Patient Guide: A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 13 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05971693
Status: ACTIVE_NOT_RECRUITING
Condition: Atrial Fibrillation
Phase: NA

Where You Can Participate

This study is available at 13 locations across the country.

Top locations include:
  • • Aalst,
  • • Brugge,
  • • Genk,
  • • And 10 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator - Join Clinical Trial NCTNCT05971693

How to Join This Clinical Trial - NCTNCT05971693

Learn how to participate in this NA trial studying an investigational therapy for Atrial Fibrillation. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Atrial Fibrillation. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Atrial Fibrillation
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05971693 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Aalst, 9300 - Belgium

Status: Contact for availability

Clinical Research Site

Brugge, 8000 - Belgium

Status: Contact for availability

Clinical Research Site

Genk, 3600 - Belgium

Status: Contact for availability

Clinical Research Site

Hasselt, 3500 - Belgium

Status: Contact for availability

Clinical Research Site

Montreal, Quebec H1T 1C8 - Canada

Status: Contact for availability

Clinical Research Site

Montreal, Quebec H3G 1A4 - Canada

Status: Contact for availability

Clinical Research Site

Split, 21000 - Croatia

Status: Contact for availability

Clinical Research Site

Prague, 140 21 - Czechia

Status: Contact for availability

Clinical Research Site

Prague, 150 30 District 5 - Czechia

Status: Contact for availability

Clinical Research Site

Frankfurt a.M., 60431 - Germany

Status: Contact for availability

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Atrial Fibrillation:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships